BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Turbine Simulated Cell Technologies Ltd.

Headquarters: Budapest, Hungary
Year Founded: 2016
Status: Private

BioCentury | Apr 2, 2024
Deals

Deals report: Abingworth and Blackstone bet on late-stage programs

Plus: Gilead acquires Xilio’s IL-12 program and Harmonic-Turbine to co-develop dark kinase therapy for cancer
BioCentury | Sep 29, 2023
Management Tracks

Novartis veteran Fox to head Teva’s U.S. commercial business

Plus: Rich Scott succeeding Chris Wigley at Genomics England, and updates from Sonoma, PIC, Turbine and LCRF
BioCentury | Jun 21, 2023
Deals

June 20 Quick Takes: FDA approves argenx’s subcutaneous Vyvgart

Plus: Clozel provides Idorsia cash lifeline, a clinical hold for Arcellx and updates from Vera, Denali, Delve Bio and Turbine
BioCentury | Nov 22, 2022
Finance

Nov. 22 Quick Takes: Brandon, Jeito lead €50M round for CatalYm

Plus Arvinas falls on protein degradation data and updates from Turbine, GSK, argenx and more
Items per page:
1 - 4 of 4